Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation

Background—Increased inactivation of nitric oxide by superoxide (O2·−) contributes to endothelial dysfunction in patients with coronary disease (CAD). We therefore characterized the vascular activities of xanthine oxidase and NAD(P)H oxidase, 2 major O2·−-producing enzyme systems, and their relationship with flow-dependent, endothelium-mediated vasodilation (FDD) in patients with CAD. Methods and Results—Xanthine- and NAD(P)H-mediated O2·− formation was determined in coronary arteries from 10 patients with CAD and 10 controls by using electron spin resonance spectroscopy. Furthermore, activity of endothelium-bound xanthine oxidase in vivo and FDD of the radial artery were determined in 21 patients with CAD and 10 controls. FDD was measured before and after infusion of the antioxidant vitamin C (25 mg/min i.a.) to determine the portion of FDD inhibited by radicals. In coronary arteries from patients with CAD, xanthine- and NAD(P)H-mediated O2·− formation was increased compared with controls (xanthine: 12±2 versus 7±1 nmol O2·−/&mgr;g protein; NADH: 11±1 versus 7±1 nmol O2·−/&mgr;g protein; and NADPH: 12±2 versus 9±1 nmol O2·−/&mgr;g protein; each P <0.05). Endothelium-bound xanthine oxidase activity was increased by >200% in patients with CAD (25±4 versus 9±1 nmol O2·−/&mgr;L plasma per min;P <0.05) and correlated inversely with FDD (r =−0.55;P <0.05) and positively with the effect of vitamin C on FDD (r =0.54;P <0.05). Conclusions—The present study represents the first electron spin resonance measurements of xanthine and NAD(P)H oxidase activity in human coronary arteries and supports the concept that increased activities of both enzymes contribute to increased vascular oxidant stress in patients with CAD. Furthermore, the present study suggests that increased xanthine oxidase activity contributes to endothelial dysfunction in patients with CAD and may thereby promote the atherosclerotic process.

[1]  R. Busse,et al.  Endothelium-Derived Hyperpolarizing Factor Synthase (Cytochrome P450 2C9) Is a Functionally Significant Source of Reactive Oxygen Species in Coronary Arteries , 2001, Circulation research.

[2]  J. Keaney,et al.  Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.

[3]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[4]  S. Marklund,et al.  Binding of Xanthine Oxidase to Vascular Endothelium , 1999, The Journal of Biological Chemistry.

[5]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[6]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[7]  U. Ryan,et al.  Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. , 1992, The Journal of clinical investigation.

[8]  B. Fink,et al.  Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. , 1999, Free radical biology & medicine.

[9]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[10]  H. Drexler,et al.  Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.

[11]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[12]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[13]  Y. Hayashi,et al.  Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.

[14]  S. Vickers,et al.  Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. , 1998, Surgery.

[15]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[16]  M. Benboubetra,et al.  A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. , 1998, Free radical research.

[17]  D. Harrison,et al.  Oxidative stress and vascular damage in hypertension , 2001, Coronary artery disease.

[18]  A. Quyyumi,et al.  Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.

[19]  A. Bindoli,et al.  Antioxidant properties of clozapine and related neuroleptics. , 1998, Free radical research.

[20]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[21]  D. Harrison,et al.  Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.

[22]  H. Drexler,et al.  Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.

[23]  Friedrich C. Luft,et al.  Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes , 2001, Hypertension.

[24]  B. Fink,et al.  A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. , 2000, Free radical biology & medicine.

[25]  K. Hirano,et al.  Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. , 1993, The Biochemical journal.

[26]  E. Bassenge,et al.  Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. , 1997, Biochemical and biophysical research communications.

[27]  J A Thompson,et al.  Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Harrison,et al.  Oxidant stress as a marker for cardiovascular events: Ox marks the spot. , 2001, Circulation.

[29]  J. Mehta,et al.  Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. , 1994, Circulation.

[30]  F. Stirpe,et al.  The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). , 1969, The Journal of biological chemistry.

[31]  D. Tosh,et al.  Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture , 1998, FEBS letters.